Mapping our History, Building a
From our start in 2010, with a handful of scientists and developers, each committed to discovering new oncology treatments and improving access to patients...
...To today, with a global team of more than 8,000 colleagues and more than 30 offices across five continents – including one of the world’s largest oncology research teams – a rich pipeline, strong partnerships, and commercial products. Our global clinical development program includes clinical trials in more than 45 countries.
We have no borders.
Except as otherwise indicated, products have not been approved for marketing and their safety and efficacy have not been established in any jurisdiction.
We’re a dynamic company, with a bold vision and bright future. We’re looking for highly motivated colleagues who can collaborate with us as we build a company that will have a lasting impact in the global fight against cancer.
Our focus is on molecularly-targeted and immuno-oncology cancer therapeutics as both monotherapies and for use in combination treatments to have a meaningful and lasting impact on cancer patients.